Congratulations to Dr. Elliman and his team at Orbsen Therapeutics for their nomination for Spin-Out Company Impact Award, an annual Knowledge Transfer Ireland Impact Award. “We are honoured to be nominated for KTI Spin-out Company of the Year. It recognises the huge efforts made by our own research team and our network of research partners to move […]
Author Archive for: merlin_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud merlin_admin contributed a whooping 44 entries.
Entries by merlin_admin
You can read more about our work in the first year of the project here. .
The MERLIN team met in Rotterdam 12 – 13 February 2015 to discuss progress in the first year of the project, and to make plans for the coming year. We’ve learned more about how MSC work in our in vitro and in vivo studies, and planning is well underway for the planned clinical trial with PSC patients. […]
Steve Elliman of Orbsen Therapeutics has been interviewed by EuroStemCell – you can find videos of the interview by clicking here.
MERLIN has now been added to EuroStemCell’s Connections. EuroStemCell is a European partnership of scientists, clinicians, ethicists, social scientists and science communicators. Launched in March 2010, the partnership unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. http://www.eurostemcell.org/connections/merlin
MERLIN researcher Gideon Hirschfield of the University of Birmingham gave a talk about current and future therapies for PSC to patients. Watch a video of the presentation here.
MERLIN researcher Steve Elliman of Orbsen Therapeutics presented at the 8th Annual UK MSC meeting hosted by REMEDI in Galway 29 – 30 Oct, 2014. To read more about the conference, and to see a list of the other speakers, click here.
A new page dedicated to related publications has now gone live on the MERLIN site. This page can be accessed by following this link, and it will be updated throughout the project.
MERLIN recently received coverage on the Primary Sclerosing Cholangitis Support website. PSC Support is the UK charity dedicated to helping people affected by Primary Sclerosing Cholangitis (PSC). PSC Support is run by a small team of volunteers, totally funded from charitable donations, and here to help anyone affected by Primary Sclerosing Cholangitis. Our objectives are to: provide […]
Project Partner Orbsen Therapeutics presented at the ISCT Paris Conference on April 22nd 2014, in a session entitled “EU funded projects in Cell Therapy”.
- RT @ALIVER_EU: Organ transplants hit an all-time high in 2017. But it’s a bittersweet win t.co/gDEvpWdtgz Time ago 2 Days via Twitter for iPhone
- RT @autostem2020: Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – #MSC Model Case Study https:/… Time ago 2 Days via Twitter for iPhone
- Stem cell-rich cord blood donations could increase by 'nudging' parents, study suggests t.co/5bT50Sacfa Time ago 6 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.